{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:52:24Z","timestamp":1793731944716,"version":"4.6.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Provincial Doctoral Funding Program at Shanxi Medical University","award":["SD2109"],"award-info":[{"award-number":["SD2109"]}]},{"name":"Doctoral Funding Program at Shanxi Medical University","award":["XD2143"],"award-info":[{"award-number":["XD2143"]}]},{"name":"Innovation and Technology Projects for Higher Education Institutions","award":["202122L127"],"award-info":[{"award-number":["202122L127"]}]},{"name":"Fundamental Research Program of Shanxi Province","award":["202203021221191"],"award-info":[{"award-number":["202203021221191"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-025-03108-z","type":"journal-article","created":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T18:26:05Z","timestamp":1748197565000},"page":"564-573","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of lipid-lowering drugs with venous thromboembolism outcomes: a phenome-wide association study and a drug-target Mendelian randomization study"],"prefix":"10.1007","volume":"59","author":[{"given":"Zhang","family":"Lingyu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Wanting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Qianqian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Chunfang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"3108_CR1","doi-asserted-by":"publisher","first-page":"I4","DOI":"10.1161\/01.CIR.0000078468.11849.66","volume":"107","author":"RH White","year":"2003","unstructured":"White RH (2003) The epidemiology of venous thromboembolism. Circulation 107:I4\u2013I8. https:\/\/doi.org\/10.1161\/01.CIR.0000078468.11849.66","journal-title":"Circulation"},{"key":"3108_CR2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(20)32658-1","volume":"398","author":"F Khan","year":"2021","unstructured":"Khan F, Tritschler T, Kahn SR, Rodger MA (2021) Venous thromboembolism. Lancet 398:64\u201377. https:\/\/doi.org\/10.1016\/S0140-6736(20)32658-1","journal-title":"Lancet"},{"key":"3108_CR3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1067\/j.cpsurg.2015.04.003","volume":"52","author":"DM Coleman","year":"2015","unstructured":"Coleman DM, Obi A, Henke PK (2015) Update in venous thromboembolism pathophysiology, diagnosis, and treatment for surgical patients. Curr Probl Surg 52:233\u2013259. https:\/\/doi.org\/10.1067\/j.cpsurg.2015.04.003","journal-title":"Curr Probl Surg"},{"key":"3108_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cells11203214","author":"M Heestermans","year":"2022","unstructured":"Heestermans M, Poenou G, Hamzeh-Cognasse H, Cognasse F, Bertoletti L (2022) Anticoagulants: a short history, their mechanism of action, pharmacology, and indications. Cells. https:\/\/doi.org\/10.3390\/cells11203214","journal-title":"Cells"},{"key":"3108_CR5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.2478\/acph-2022-0034","volume":"72","author":"S Margetic","year":"2022","unstructured":"Margetic S, Goreta SS, Celap I, Razum M (2022) Direct oral anticoagulants (doacs): from the laboratory point of view. Acta Pharm 72:459\u2013482. https:\/\/doi.org\/10.2478\/acph-2022-0034","journal-title":"Acta Pharm"},{"key":"3108_CR6","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1111\/jth.15776","volume":"20","author":"PL den Exter","year":"2022","unstructured":"den Exter PL, Woller SC, Robert-Ebadi H, Masias C, Morange PE, Castelli D, Hansen JB, Geersing GJ, Siegal DM, de Wit K, Klok FA (2022) Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: communication from the isth ssc subcommittee on predictive and diagnostic variables in thrombotic disease. J Thromb Haemost 20:1910\u20131919. https:\/\/doi.org\/10.1111\/jth.15776","journal-title":"J Thromb Haemost"},{"key":"3108_CR7","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/ejhg.2014.123","volume":"23","author":"Z Ye","year":"2015","unstructured":"Ye Z, Mayer J, Ivacic L, Zhou Z, He M, Schrodi SJ, Page D, Brilliant MH, Hebbring SJ (2015) Phenome-wide association studies (phewass) for functional variants. Eur J Hum Genet 23:523\u2013529. https:\/\/doi.org\/10.1038\/ejhg.2014.123","journal-title":"Eur J Hum Genet"},{"key":"3108_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/rth2.12003","volume":"1","author":"SK Braekkan","year":"2017","unstructured":"Braekkan SK, Caram-Deelder C, Siegerink B, van Hylckama VA, le Cessie S, Rosendaal FR, Cannegieter SC, Lijfering WM (2017) Statin use and risk of recurrent venous thrombosis: results from the mega follow-up study. Res Pract Thromb Haemost 1:112\u2013119. https:\/\/doi.org\/10.1002\/rth2.12003","journal-title":"Res Pract Thromb Haemost"},{"key":"3108_CR9","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1111\/jth.13334","volume":"14","author":"NL Smith","year":"2016","unstructured":"Smith NL, Harrington LB, Blondon M, Wiggins KL, Floyd JS, Sitlani CM, Mcknight B, Larson EB, Rosendaal FR, Heckbert SR, Psaty BM (2016) The association of statin therapy with the risk of recurrent venous thrombosis. J Thromb Haemost 14:1384\u20131392. https:\/\/doi.org\/10.1111\/jth.13334","journal-title":"J Thromb Haemost"},{"key":"3108_CR10","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.thromres.2015.04.005","volume":"135","author":"AA Ashrani","year":"2015","unstructured":"Ashrani AA, Barsoum MK, Crusan DJ, Petterson TM, Bailey KR, Heit JA (2015) Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study. Thromb Res 135:1110\u20131116. https:\/\/doi.org\/10.1016\/j.thromres.2015.04.005","journal-title":"Thromb Res"},{"key":"3108_CR11","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1056\/NEJMoa0900241","volume":"360","author":"RJ Glynn","year":"2009","unstructured":"Glynn RJ, Danielson E, Fonseca FA, Genest J, Gotto AJ, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, Macfadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Ridker PM (2009) A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med 360:1851\u20131861. https:\/\/doi.org\/10.1056\/NEJMoa0900241","journal-title":"N Engl J Med"},{"key":"3108_CR12","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1056\/NEJMoa1600176","volume":"374","author":"S Yusuf","year":"2016","unstructured":"Yusuf S, Bosch J, Dagenais G, Zhu J, Xavier D, Liu L, Pais P, Lopez-Jaramillo P, Leiter LA, Dans A, Avezum A, Piegas LS, Parkhomenko A, Keltai K, Keltai M, Sliwa K, Peters RJ, Held C, Chazova I, Yusoff K, Lewis BS, Jansky P, Khunti K, Toff WD, Reid CM, Varigos J, Sanchez-Vallejo G, Mckelvie R, Pogue J, Jung H, Gao P, Diaz R, Lonn E (2016) Cholesterol lowering in intermediate-risk persons without cardiovascular disease. N Engl J Med 374:2021\u20132031. https:\/\/doi.org\/10.1056\/NEJMoa1600176","journal-title":"N Engl J Med"},{"key":"3108_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2021.106931","volume":"142","author":"H Zhu","year":"2022","unstructured":"Zhu H, Zheng H, Xu T, Liu X, Liu X, Sun L, Pan XF, Mai W, Cai X, Huang Y (2022) Effects of statins in primary and secondary prevention for venous thromboembolism events: a meta analysis. Vasc Pharmacol 142:106931. https:\/\/doi.org\/10.1016\/j.vph.2021.106931","journal-title":"Vasc Pharmacol"},{"key":"3108_CR14","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1038\/s41467-020-16969-0","volume":"11","author":"AF Schmidt","year":"2020","unstructured":"Schmidt AF, Finan C, Gordillo-Maranon M, Asselbergs FW, Freitag DF, Patel RS, Tyl B, Chopade S, Faraway R, Zwierzyna M, Hingorani AD (2020) Genetic drug target validation using mendelian randomisation. Nat Commun 11:3255. https:\/\/doi.org\/10.1038\/s41467-020-16969-0","journal-title":"Nat Commun"},{"key":"3108_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41588-022-01286-7","volume":"55","author":"J Ghouse","year":"2023","unstructured":"Ghouse J, Tragante V, Ahlberg G, Rand SA, Jespersen JB, Leinoe EB, Vissing CR, Trudso L, Jonsdottir I, Banasik K, Brunak S, Ostrowski SR, Pedersen OB, Sorensen E, Erikstrup C, Bruun MT, Nielsen KR, Kober L, Christensen AH, Iversen K, Jones D, Knowlton KU, Nadauld L, Halldorsson GH, Ferkingstad E, Olafsson I, Gretarsdottir S, Onundarson PT, Sulem P, Thorsteinsdottir U, Thorgeirsson G, Gudbjartsson DF, Stefansson K, Holm H, Olesen MS, Bundgaard H (2023) Genome-wide meta-analysis identifies 93 risk loci and enables risk prediction equivalent to monogenic forms of venous thromboembolism. Nat Genet 55:399\u2013409. https:\/\/doi.org\/10.1038\/s41588-022-01286-7","journal-title":"Nat Genet"},{"key":"3108_CR16","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1158\/1055-9965.EPI-20-0113","volume":"29","author":"EC Semmes","year":"2020","unstructured":"Semmes EC, Vijayakrishnan J, Zhang C, Hurst JH, Houlston RS, Walsh KM (2020) Leveraging genome and phenome-wide association studies to investigate genetic risk of acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev 29:1606\u20131614. https:\/\/doi.org\/10.1158\/1055-9965.EPI-20-0113","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3108_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12916-021-02013-5","volume":"19","author":"S Li","year":"2021","unstructured":"Li S, Schooling CM (2021) A phenome-wide association study of genetically mimicked statins. Bmc Med 19:151. https:\/\/doi.org\/10.1186\/s12916-021-02013-5","journal-title":"Bmc Med"},{"key":"3108_CR18","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ng.3538","volume":"48","author":"Z Zhu","year":"2016","unstructured":"Zhu Z, Zhang F, Hu H, Bakshi A, Robinson MR, Powell JE, Montgomery GW, Goddard ME, Wray NR, Visscher PM, Yang J (2016) Integration of summary data from gwas and eqtl studies predicts complex trait gene targets. Nat Genet 48:481\u2013487. https:\/\/doi.org\/10.1038\/ng.3538","journal-title":"Nat Genet"},{"key":"3108_CR19","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.ajhg.2022.04.001","volume":"109","author":"V Zuber","year":"2022","unstructured":"Zuber V, Grinberg NF, Gill D, Manipur I, Slob E, Patel A, Wallace C, Burgess S (2022) Combining evidence from mendelian randomization and colocalization: review and comparison of approaches. Am J Hum Genet 109:767\u2013782. https:\/\/doi.org\/10.1016\/j.ajhg.2022.04.001","journal-title":"Am J Hum Genet"},{"key":"3108_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei C, Vukcevic D, Schadt EE, Franke L, Hingorani AD, Wallace C, Plagnol V (2014) Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. Plos Genet 10:e1004383. https:\/\/doi.org\/10.1371\/journal.pgen.1004383","journal-title":"Plos Genet"},{"key":"3108_CR21","doi-asserted-by":"publisher","first-page":"1307944","DOI":"10.3389\/fendo.2024.1307944","volume":"15","author":"S Chen","year":"2024","unstructured":"Chen S, Zhou Z, Zhou Z, Liu Y, Sun S, Huang K, Yang Q, Guo Y (2024) Non-targeted metabolomics revealed novel links between serum metabolites and primary ovarian insufficiency: a mendelian randomization study. Front Endocrinol 15:1307944. https:\/\/doi.org\/10.3389\/fendo.2024.1307944","journal-title":"Front Endocrinol"},{"key":"3108_CR22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/jamadermatol.2022.6051","volume":"159","author":"SS Zhao","year":"2023","unstructured":"Zhao SS, Yiu Z, Barton A, Bowes J (2023) Association of lipid-lowering drugs with risk of psoriasis: a mendelian randomization study. Jama Dermatol 159:275\u2013280. https:\/\/doi.org\/10.1001\/jamadermatol.2022.6051","journal-title":"Jama Dermatol"},{"key":"3108_CR23","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1111\/jth.14004","volume":"16","author":"S Ades","year":"2018","unstructured":"Ades S, Douce D, Holmes CE, Cory S, Prior S, Butenas S, Callas P, Cushman M (2018) Effect of rosuvastatin on risk markers for venous thromboembolism in cancer. J Thromb Haemost 16:1099\u20131106. https:\/\/doi.org\/10.1111\/jth.14004","journal-title":"J Thromb Haemost"},{"key":"3108_CR24","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.numecd.2023.02.023","volume":"33","author":"XS Ma","year":"2023","unstructured":"Ma XS, Sun J, Geng R, Zhao Y, Xu WZ, Liu YH, Jiang YN, Li YQ (2023) Statins and risk of venous thromboembolic diseases: a two-sample mendelian randomization study. Nutr Metab Carbiovasc Dis 33:1087\u20131092. https:\/\/doi.org\/10.1016\/j.numecd.2023.02.023","journal-title":"Nutr Metab Carbiovasc Dis"},{"key":"3108_CR25","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1161\/CIRCULATIONAHA.120.046397","volume":"141","author":"NA Marston","year":"2020","unstructured":"Marston NA, Gurmu Y, Melloni G, Bonaca M, Gencer B, Sever PS, Pedersen TR, Keech AC, Roselli C, Lubitz SA, Ellinor PT, O\u2019Donoghue ML, Giugliano RP, Ruff CT, Sabatine MS (2020) The effect of pcsk9 (proprotein convertase subtilisin\/kexin type 9) inhibition on the risk of venous thromboembolism. Circulation 141:1600\u20131607. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.046397","journal-title":"Circulation"},{"key":"3108_CR26","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1093\/eurheartj\/ehae361","volume":"45","author":"IT Farmakis","year":"2024","unstructured":"Farmakis IT, Christodoulou KC, Hobohm L, Konstantinides SV, Valerio L (2024) Lipid lowering for prevention of venous thromboembolism: a network meta-analysis. Eur Heart J 45:3219\u20133227. https:\/\/doi.org\/10.1093\/eurheartj\/ehae361","journal-title":"Eur Heart J"},{"key":"3108_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000040770","volume":"103","author":"M Li","year":"2024","unstructured":"Li M, Duan H, Luo J, Tan Y, Liu M, Zhao X, Shi D, Ma X (2024) Genetic correlation between genes targeted by lipid-lowering drugs and venous thromboembolism: a drug-target mendelian randomization study. Med (Baltimore) 103:e40770. https:\/\/doi.org\/10.1097\/MD.0000000000040770","journal-title":"Med (Baltimore)"},{"key":"3108_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abg3188","author":"M Hu","year":"2021","unstructured":"Hu M, Yang F, Huang Y, You X, Liu D, Sun S, Sui SF (2021) Structural insights into the mechanism of human npc1l1-mediated cholesterol uptake. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.abg3188","journal-title":"Sci Adv"},{"key":"3108_CR29","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1172\/JCI30060","volume":"117","author":"RE Temel","year":"2007","unstructured":"Temel RE, Tang W, Ma Y, Rudel LL, Willingham MC, Ioannou YA, Davies JP, Nilsson LM, Yu L (2007) Hepatic niemann-pick c1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. J Clin Invest 117:1968\u20131978. https:\/\/doi.org\/10.1172\/JCI30060","journal-title":"J Clin Invest"},{"key":"3108_CR30","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1126\/science.1093131","volume":"303","author":"SW Altmann","year":"2004","unstructured":"Altmann SW, Davis HJ, Zhu LJ, Yao X, Hoos LM, Tetzloff G, Iyer SP, Maguire M, Golovko A, Zeng M, Wang L, Murgolo N, Graziano MP (2004) Niemann-pick c1 like 1 protein is critical for intestinal cholesterol absorption. Science 303:1201\u20131204. https:\/\/doi.org\/10.1126\/science.1093131","journal-title":"Science"},{"key":"3108_CR31","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/joim.12981","volume":"287","author":"A Vuorio","year":"2020","unstructured":"Vuorio A, Watts GF, Schneider WJ, Tsimikas S, Kovanen PT (2020) Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunities. J Intern Med 287:2\u201318. https:\/\/doi.org\/10.1111\/joim.12981","journal-title":"J Intern Med"},{"key":"3108_CR32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/s0049-3848(97)00192-8","volume":"88","author":"T Kawasaki","year":"1997","unstructured":"Kawasaki T, Kambayashi J, Ariyoshi H, Sakon M, Suehisa E, Monden M (1997) Hypercholesterolemia as a risk factor for deep-vein thrombosis. Thromb Res 88:67\u201373. https:\/\/doi.org\/10.1016\/s0049-3848(97)00192-8","journal-title":"Thromb Res"},{"key":"3108_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.rppneu.2011.03.006","volume":"17","author":"L Jara-Palomares","year":"2011","unstructured":"Jara-Palomares L, Otero-Candelera R, Elias-Hernandez T, Cayuela-Dominguez A, Ferrer-Galvan M, Alfaro MJ, Montero E, Barrot-Cortes E (2011) Dyslipidemia as a long-term marker for survival in pulmonary embolism. Rev Port Pneumol 17:205\u2013210. https:\/\/doi.org\/10.1016\/j.rppneu.2011.03.006","journal-title":"Rev Port Pneumol"},{"key":"3108_CR34","first-page":"1595","volume":"68","author":"S Morris","year":"2003","unstructured":"Morris S, Tiller R (2003) Ezetimibe for hypercholesterolemia. Am Fam Physician 68:1595\u20131596","journal-title":"Am Fam Physician"},{"key":"3108_CR35","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.2147\/VHRM.S13496","volume":"6","author":"I Hamilton-Craig","year":"2010","unstructured":"Hamilton-Craig I, Kostner K, Colquhoun D, Woodhouse S (2010) Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia. Vasc Health Risk Manag 6:1023\u20131037. https:\/\/doi.org\/10.2147\/VHRM.S13496","journal-title":"Vasc Health Risk Manag"},{"key":"3108_CR36","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","volume":"372","author":"CP Cannon","year":"2015","unstructured":"Cannon CP, Blazing MA, Giugliano RP, Mccagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM (2015) Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med 372:2387\u20132397. https:\/\/doi.org\/10.1056\/NEJMoa1410489","journal-title":"N Engl J Med"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03108-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-025-03108-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03108-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T13:41:37Z","timestamp":1780926097000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-025-03108-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["3108"],"URL":"https:\/\/doi.org\/10.1007\/s11239-025-03108-z","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]},"assertion":[{"value":"6 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All the authors provided consent for the publication of this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}